Dr. Lal Pathlabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2025 ,inter alia, to consider and approve Unaudited (Standalone and Consolidated) Financial Results for the quarter and nine months ended 31-12-2024 and to consider the proposal for declaration of 3rd interim dividend if any, for the financial year 2024-2025